ASELAGE STEVE 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Jun 2, 2022
Insider Transaction Report
Form 4
ASELAGE STEVE
Director
Transactions
- Award
Common Stock
2022-05-31$9.31/sh+569$5,297→ 33,728 total
Footnotes (1)
- [F1]Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250, prorated to $10,597.83 based on the increase in the annual retainer fee effective April 18, 2022.